"10.1371_journal.pone.0077397","plos one","2013-10-09T00:00:00Z","Shinji Shimato; Lisa M Anderson; Martin Asslaber; Jeffrey N Bruce; Peter Canoll; David E Anderson; Richard C E Anderson","Department of Neurosurgery, Gabriele Bartoli Brain Tumor Research Laboratory, Columbia University, New York, New York, United States of America; Erinyes Biotechnologies, LLC, Boston, Massachusetts, United States of America; Department of Pathology, Medical University of Graz, Graz, Austria; Department of Pathology, Columbia University, New York, New York, United States of America","Conceived and designed the experiments: SS LMA DEA RCA. Performed the experiments: SS LMA DEA MA. Analyzed the data: SS LMA DEA MA RCA. Contributed reagents/materials/analysis tools: JB PC MA. Wrote the manuscript: SS LMA DEA MA PC JB RCA.","Two of the authors of this manuscript (LMA and DEA) are managers of Erinyes Biotechnologies, LLC. A patent was filed on 6/19/13 by Columbia University titled “Caveolin-1 inhibits myeloid cells in glioblastoma” (Application serial number
61/837,164). This does not alter the authors' adherence to all the PLOS ONE policies on sharing
data and materials.","2013","10","Shinji Shimato","SS",7,TRUE,4,4,5,7,TRUE,TRUE,FALSE,0,NA,FALSE
